PandemieGrippaleV1, PubMed, Curation, bibRecord, 000186

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.

Identifieur interne : 000186 ( PubMed/Curation ); précédent : 000185; suivant : 000187

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.

Auteurs : Gro Tunheim [Norvège] ; Ida Laake [Norvège] ; Anna Hayman Robertson [Norvège] ; Kristian Waalen [Norvège] ; Olav Hungnes [Norvège] ; Lisbeth M. Naess [Norvège] ; Rebecca J. Cox [Norvège] ; Siri Mjaaland [Norvège] ; Lill Trogstad [Norvège]

Source :

Influenza and other respiratory viruses [ 1750-2659 ] ; 2019.

RBID : pubmed:30536590

Descripteurs français

KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Anticorps antiviraux (sang), Autorapport, Enquêtes et questionnaires, Enregistrements, Femelle, Grippe humaine (immunologie), Grossesse, Humains, Indice de gravité médicale, Jeune adulte, Sous-type H1N1 du virus de la grippe A, Tests d'inhibition de l'hémagglutination, Vaccination (), Vaccins antigrippaux (usage thérapeutique), Études de cohortes.
MESH :
- immunologie : Grippe humaine.
- sang : Anticorps antiviraux.
- usage thérapeutique : Vaccins antigrippaux.
- Adolescent, Adulte, Adulte d'âge moyen, Autorapport, Enquêtes et questionnaires, Enregistrements, Femelle, Grossesse, Humains, Indice de gravité médicale, Jeune adulte, Sous-type H1N1 du virus de la grippe A, Tests d'inhibition de l'hémagglutination, Vaccination, Études de cohortes.

English descriptors

KwdEn :
- Adolescent, Adult, Antibodies, Viral (blood), Cohort Studies, Female, Hemagglutination Inhibition Tests, Humans, Influenza A Virus, H1N1 Subtype, Influenza Vaccines (therapeutic use), Influenza, Human (immunology), Middle Aged, Pregnancy, Registries, Self Report, Severity of Illness Index, Surveys and Questionnaires, Vaccination (statistics & numerical data), Young Adult.
MESH :
- chemical , blood : Antibodies, Viral.
- chemical , therapeutic use : Influenza Vaccines.
- immunology : Influenza, Human.
- statistics & numerical data : Vaccination.
- Adolescent, Adult, Cohort Studies, Female, Hemagglutination Inhibition Tests, Humans, Influenza A Virus, H1N1 Subtype, Middle Aged, Pregnancy, Registries, Self Report, Severity of Illness Index, Surveys and Questionnaires, Young Adult.

Abstract

A population-based pregnancy cohort was established in Norway to study potential effects of exposure to the 2009 influenza pandemic or pandemic vaccination during pregnancy.

DOI: 10.1111/irv.12623
PubMed: 30536590

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000186

Links to Exploration step

pubmed:30536590

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.</title>
<author><name sortKey="Tunheim, Gro" sort="Tunheim, Gro" uniqKey="Tunheim G" first="Gro" last="Tunheim">Gro Tunheim</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Laake, Ida" sort="Laake, Ida" uniqKey="Laake I" first="Ida" last="Laake">Ida Laake</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Robertson, Anna Hayman" sort="Robertson, Anna Hayman" uniqKey="Robertson A" first="Anna Hayman" last="Robertson">Anna Hayman Robertson</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Waalen, Kristian" sort="Waalen, Kristian" uniqKey="Waalen K" first="Kristian" last="Waalen">Kristian Waalen</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hungnes, Olav" sort="Hungnes, Olav" uniqKey="Hungnes O" first="Olav" last="Hungnes">Olav Hungnes</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Naess, Lisbeth M" sort="Naess, Lisbeth M" uniqKey="Naess L" first="Lisbeth M" last="Naess">Lisbeth M. Naess</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cox, Rebecca J" sort="Cox, Rebecca J" uniqKey="Cox R" first="Rebecca J" last="Cox">Rebecca J. Cox</name>
<affiliation wicri:level="1"><nlm:affiliation>K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mjaaland, Siri" sort="Mjaaland, Siri" uniqKey="Mjaaland S" first="Siri" last="Mjaaland">Siri Mjaaland</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Trogstad, Lill" sort="Trogstad, Lill" uniqKey="Trogstad L" first="Lill" last="Trogstad">Lill Trogstad</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30536590</idno>
<idno type="pmid">30536590</idno>
<idno type="doi">10.1111/irv.12623</idno>
<idno type="wicri:Area/PubMed/Corpus">000186</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000186</idno>
<idno type="wicri:Area/PubMed/Curation">000186</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000186</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.</title>
<author><name sortKey="Tunheim, Gro" sort="Tunheim, Gro" uniqKey="Tunheim G" first="Gro" last="Tunheim">Gro Tunheim</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Laake, Ida" sort="Laake, Ida" uniqKey="Laake I" first="Ida" last="Laake">Ida Laake</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Robertson, Anna Hayman" sort="Robertson, Anna Hayman" uniqKey="Robertson A" first="Anna Hayman" last="Robertson">Anna Hayman Robertson</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Waalen, Kristian" sort="Waalen, Kristian" uniqKey="Waalen K" first="Kristian" last="Waalen">Kristian Waalen</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hungnes, Olav" sort="Hungnes, Olav" uniqKey="Hungnes O" first="Olav" last="Hungnes">Olav Hungnes</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Naess, Lisbeth M" sort="Naess, Lisbeth M" uniqKey="Naess L" first="Lisbeth M" last="Naess">Lisbeth M. Naess</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cox, Rebecca J" sort="Cox, Rebecca J" uniqKey="Cox R" first="Rebecca J" last="Cox">Rebecca J. Cox</name>
<affiliation wicri:level="1"><nlm:affiliation>K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mjaaland, Siri" sort="Mjaaland, Siri" uniqKey="Mjaaland S" first="Siri" last="Mjaaland">Siri Mjaaland</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Trogstad, Lill" sort="Trogstad, Lill" uniqKey="Trogstad L" first="Lill" last="Trogstad">Lill Trogstad</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Influenza and other respiratory viruses</title>
<idno type="eISSN">1750-2659</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Antibodies, Viral (blood)</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza Vaccines (therapeutic use)</term>
<term>Influenza, Human (immunology)</term>
<term>Middle Aged</term>
<term>Pregnancy</term>
<term>Registries</term>
<term>Self Report</term>
<term>Severity of Illness Index</term>
<term>Surveys and Questionnaires</term>
<term>Vaccination (statistics & numerical data)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anticorps antiviraux (sang)</term>
<term>Autorapport</term>
<term>Enquêtes et questionnaires</term>
<term>Enregistrements</term>
<term>Femelle</term>
<term>Grippe humaine (immunologie)</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Indice de gravité médicale</term>
<term>Jeune adulte</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Vaccination ()</term>
<term>Vaccins antigrippaux (usage thérapeutique)</term>
<term>Études de cohortes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Middle Aged</term>
<term>Pregnancy</term>
<term>Registries</term>
<term>Self Report</term>
<term>Severity of Illness Index</term>
<term>Surveys and Questionnaires</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Autorapport</term>
<term>Enquêtes et questionnaires</term>
<term>Enregistrements</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Indice de gravité médicale</term>
<term>Jeune adulte</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Vaccination</term>
<term>Études de cohortes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A population-based pregnancy cohort was established in Norway to study potential effects of exposure to the 2009 influenza pandemic or pandemic vaccination during pregnancy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30536590</PMID>
<DateCompleted><Year>2019</Year>
<Month>11</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>13</Volume>
<Issue>2</Issue>
<PubDate><Year>2019</Year>
<Month>03</Month>
</PubDate>
</JournalIssue>
<Title>Influenza and other respiratory viruses</Title>
<ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation>
</Journal>
<ArticleTitle>Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.</ArticleTitle>
<Pagination><MedlinePgn>191-200</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12623</ELocationID>
<Abstract><AbstractText Label="BACKGROUND">A population-based pregnancy cohort was established in Norway to study potential effects of exposure to the 2009 influenza pandemic or pandemic vaccination during pregnancy.</AbstractText>
<AbstractText Label="OBJECTIVES">We studied maternal A(H1N1)pdm09-specific hemagglutination inhibition (HI)-titer levels and waning in women with influenza-like illness (ILI) in pregnancy compared to vaccinated women. Moreover, we studied the association between HI-titers and self-reported severity and duration of ILI.</AbstractText>
<AbstractText Label="METHODS">HI-titers against the pandemic virus were measured in maternal blood samples obtained at birth, 3-9 months after exposure, and linked with information about pregnancy, influenza and vaccination from national registries and a cohort questionnaire.</AbstractText>
<AbstractText Label="RESULTS">Among 1821 pregnant women included, 43.7% were unvaccinated and 19.3% of these had ILI. HI-titers were low (geometric mean titer (GMT) 11.3) in the unvaccinated women with ILI. Higher HI-titers (GMT 37.8) were measured in the vaccinated women. Estimated HI-titer waning was similar for vaccinated women and women with ILI. Most ILI episodes were moderate and lasted 3-5 days. Women with ILI reporting specific influenza symptoms such as fever or cough had higher HI-titers than women without these symptoms. Women who reported being "very ill" or illness duration of >5 days had higher HI-titers than women reporting less severe illness or illness of shorter duration, respectively.</AbstractText>
<AbstractText Label="CONCLUSIONS">Antibody waning was similar in vaccinated women and women with ILI. More severe ILI or longer duration of illness was associated with higher HI-titers. Most unvaccinated pregnant women with ILI had low HI-titers, probably due to moderate illness and HI-titer waning between exposure and sampling.</AbstractText>
<CopyrightInformation>© 2018 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tunheim</LastName>
<ForeName>Gro</ForeName>
<Initials>G</Initials>
<Identifier Source="ORCID">0000-0002-8280-8243</Identifier>
<AffiliationInfo><Affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Laake</LastName>
<ForeName>Ida</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Robertson</LastName>
<ForeName>Anna Hayman</ForeName>
<Initials>AH</Initials>
<AffiliationInfo><Affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Waalen</LastName>
<ForeName>Kristian</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hungnes</LastName>
<ForeName>Olav</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Naess</LastName>
<ForeName>Lisbeth M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo><Affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cox</LastName>
<ForeName>Rebecca J</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo><Affiliation>K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>The Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Research and Development, Haukeland University Hospital, Bergen, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mjaaland</LastName>
<ForeName>Siri</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Trogstad</LastName>
<ForeName>Lill</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2019</Year>
<Month>01</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Influenza Other Respir Viruses</MedlineTA>
<NlmUniqueID>101304007</NlmUniqueID>
<ISSNLinking>1750-2640</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">antibodies</Keyword>
<Keyword MajorTopicYN="Y">influenza</Keyword>
<Keyword MajorTopicYN="Y">pandemic H1N1pdm09</Keyword>
<Keyword MajorTopicYN="Y">pregnancy</Keyword>
<Keyword MajorTopicYN="Y">vaccination</Keyword>
<Keyword MajorTopicYN="Y">waning</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year>
<Month>07</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2018</Year>
<Month>11</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30536590</ArticleId>
<ArticleId IdType="doi">10.1111/irv.12623</ArticleId>
<ArticleId IdType="pmc">PMC6379636</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>BMC Infect Dis. 2014 Jun 11;14:319</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24916787</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2010 Aug;16(8):1265-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20678321</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2011 May;5(3):148-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21477133</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Immunol. 2015 Jun 04;6:289</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26089824</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2014 Jun 5;370(23):2211-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24897084</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2012 Mar 20;12:63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22429643</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Jan 24;368(4):333-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23323868</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(3):e33048</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22457731</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Reprod Immunol. 2015 Feb;107:1-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25453203</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2012 Jan 5;30(2):210-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22100887</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2017 Nov 16;12(11):e0188055</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29145441</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Oct;86(20):11115-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22855494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2011 Jul;8(7):e1001053</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21750667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1937 Jan 31;65(2):251-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19870599</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Matern Child Health J. 2014 Aug;18(6):1454-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24162551</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2011 May 1;203(9):1309-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21378375</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2010 Mar 27;375(9720):1100-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20096450</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2010 Aug 05;15(31):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20738992</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Obstet Gynecol Scand. 2015 Aug;94(8):833-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25958884</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2013 May;7(3):431-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22913369</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2016 Jun 10;65(22):567-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27281364</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2016 May 1;62(9):1111-1118</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27060790</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2012 May 10;17(19):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22607964</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2015 Feb 1;191(3):325-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25506631</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Obstet Gynecol Scand. 2000 Jun;79(6):435-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10857866</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011 Feb 09;6(2):e16809</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21347418</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 2011 Jul;205(1):10-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21345415</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Nov 04;90(2):1023-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26537681</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2012 Apr 19;17(16):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22551462</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2015 Aug 7;33(33):4146-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26057137</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2010 Apr;16(4):317-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20121827</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2012 Jul 6;30(32):4785-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22633868</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2017 May;11(3):202-210</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28294578</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(1):e30018</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22253862</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19465683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2014 Aug;60(4):367-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24930707</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2015 Nov 25;10(11):e0143281</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26606759</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Fam Pract. 2012 Apr;29(2):139-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21896504</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2012 Oct;16(10):e714-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22784546</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2014 Jul 28;14:414</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25066592</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2007 Nov 8;357(19):1903-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17989383</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011;6(11):e28063</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22132212</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2012 Sep;6(5):367-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22074016</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2011 Jun;49(6):2210-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21471339</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2019 Jan 18;68(3):382-392</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29893797</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2010 Aug 1;51(3):274-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20575664</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000186 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000186 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:30536590
   |texte=   Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:30536590" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki